The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient

Transplantation. 1994 Jun 27;57(12):1813-5.

Authors

Y Taguchi¹, D T Purtilo, M Okano

Affiliation

¹ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198-3135.

PMID: 8016889

No abstract available

Publication types

Case Reports

MeSH terms

Antigens, Viral / blood
Capsid / immunology
Child, Preschool
Cyclosporine / therapeutic use
DNA-Binding Proteins / blood
Epstein-Barr Virus Nuclear Antigens
Female
Herpesviridae Infections / blood
Herpesviridae Infections / complications*
Herpesviridae Infections / immunology
Herpesvirus 4, Human* / immunology
Herpesvirus 4, Human* / isolation & purification
Humans
Immunoglobulin G / blood
Immunoglobulin M / blood
Immunoglobulins, Intravenous / therapeutic use*
Interferon-alpha / therapeutic use*
Liver Function Tests
Liver Transplantation* / immunology
Lymphocytes / immunology
Lymphocytes / microbiology
Lymphoproliferative Disorders / immunology
Lymphoproliferative Disorders / microbiology
Lymphoproliferative Disorders / therapy*
Prednisolone / therapeutic use
alpha 1-Antitrypsin Deficiency

Substances

Antigens, Viral
DNA-Binding Proteins
Epstein-Barr Virus Nuclear Antigens
Immunoglobulin G
Immunoglobulin M
Immunoglobulins, Intravenous
Interferon-alpha
Cyclosporine
Prednisolone